Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -81.91%1.41M | 759.62%4.18M | -278.19%-3.43M | 91.77%-372K | -92.53%1.04M | -68.91%7.8M | -634K | -908K | -4.52M | 13.86M |
| Net profit before non-cash adjustment | 16.51%30.89M | 26.00%8.1M | 20.01%10.09M | -9.07%5.93M | 31.29%6.76M | 40.11%26.51M | --6.43M | --8.41M | --6.52M | --5.15M |
| Total adjustment of non-cash items | 39.45%3.57M | 1,724.36%1.42M | 6.56%1.32M | 43.84%666K | -78.43%170K | 185.36%2.56M | --78K | --1.23M | --463K | --788K |
| -Depreciation and amortization | 50.05%4.93M | 87.24%1.54M | 82.80%1.5M | 30.15%1.06M | 0.12%827K | 12.66%3.29M | --823K | --820K | --816K | --826K |
| -Reversal of impairment losses recognized in profit and loss | 574.51%242K | -288.24%-198K | --0 | ---- | ---- | -122.85%-51K | ---51K | --0 | ---- | ---- |
| -Disposal profit | -96.26%4K | --0 | --5K | -104.00%-1K | --0 | 179.15%107K | --1K | --0 | --25K | --81K |
| -Net exchange gains and losses | 186.44%338K | 385.14%211K | -72.73%96K | 236.23%282K | -634.04%-251K | 106.65%118K | ---74K | --352K | ---207K | --47K |
| -Other non-cash items | -116.41%-1.94M | 78.90%-131K | -559.68%-285K | -553.22%-1.12M | -144.58%-406K | -169.65%-896K | ---621K | --62K | ---171K | ---166K |
| Changes in working capital | -55.37%-33.05M | 25.19%-5.34M | -40.66%-14.84M | 39.92%-6.97M | -173.57%-5.9M | -503.04%-21.27M | ---7.14M | ---10.55M | ---11.59M | --8.02M |
| -Change in receivables | -207.32%-30.49M | -26.53%-14.15M | -187.31%-15.5M | 378.41%1.65M | -134.27%-2.49M | -155.31%-9.92M | ---11.18M | ---5.4M | ---593K | --7.25M |
| -Change in inventory | -184.00%-588K | 56.04%142K | -244.51%-685K | -162.86%-44K | -101.54%-1K | 719.53%700K | --91K | --474K | --70K | --65K |
| -Change in payables | 10.33%3.02M | 28.32%4.9M | -31.20%1.29M | -480.79%-1.91M | 51.84%-1.27M | 110.47%2.74M | --3.82M | --1.88M | ---328K | ---2.63M |
| -Changes in other current assets | 66.21%-5M | 2,838.28%3.76M | 100.72%54K | 37.94%-6.67M | -164.38%-2.15M | -208.58%-14.79M | --128K | ---7.51M | ---10.74M | --3.33M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | 4.46%1.29M | -38.81%268K | 17.51%302K | 19.46%307K | 46.26%411K | 58.62%1.23M | 438K | 257K | 257K | 281K |
| Tax refund paid | -12.95%-8.78M | 36.83%-2.29M | -42.75%-2.58M | -56.65%-1.63M | -74.51%-2.29M | -30.99%-7.78M | -3.62M | -1.81M | -1.04M | -1.31M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -582.78%-6.08M | 156.78%2.17M | -132.40%-5.71M | 68.09%-1.69M | -106.60%-847K | -93.68%1.26M | ---3.81M | ---2.46M | ---5.3M | --12.83M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -704.36%-7.38M | -1,772.47%-4.63M | -974.68%-1.66M | 62.53%-175K | -1,758.00%-929K | 66.35%-918K | ---247K | ---154K | ---467K | ---50K |
| Net business purchase and sale | ---2.4M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net changes in other investments | -3,540.00%-172K | -114.01%-22K | -4.76%-44K | 69.12%-21K | -102.38%-85K | 100.13%5K | --157K | ---42K | ---68K | ---42K |
| Investing cash flow | -990.14%-9.95M | -5,063.33%-4.65M | -766.84%-1.7M | -384.67%-2.59M | -1,002.17%-1.01M | 86.37%-913K | ---90K | ---196K | ---535K | ---92K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 171.68%5.95M | 2,048.67%5.85M | 110.18%543K | 98.82%-26K | 8.15%-417K | -303.75%-8.3M | ---300K | ---5.34M | ---2.21M | ---454K |
| Net common stock issuance | --0 | --0 | ---- | ---- | ---- | --33M | --1M | ---- | ---- | ---- |
| Increase or decrease of lease financing | 303.24%1.38M | 3.29%-147K | 1,144.56%2.02M | -250.00%-511K | 111.70%22K | -22.57%-679K | ---152K | ---193K | ---146K | ---188K |
| Issuance fees | --0 | ---- | ---- | ---- | ---- | ---1M | ---- | ---- | ---- | ---- |
| Cash dividends paid | 31.25%-6.88M | --0 | --0 | --0 | -37.50%-6.88M | 23.08%-10M | --0 | --0 | ---5M | ---5M |
| Interest paid (cash flow from financing activities) | 37.22%-221K | -480.00%-145K | 81.15%-23K | 54.44%-41K | 89.57%-12K | 21.60%-352K | ---25K | ---122K | ---90K | ---115K |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | -203.43%-551K | ---- | ---- | ---543K | ---7K |
| Financing cash flow | -98.10%230K | 640.27%5.55M | -90.57%2.54M | 92.76%-578K | -26.34%-7.28M | 178.09%12.12M | ---1.03M | --26.9M | ---7.98M | ---5.76M |
| Net cash flow | ||||||||||
| Beginning cash position | 31.72%51.56M | -42.31%32.63M | 15.80%37.69M | -4.04%42.76M | 31.72%51.56M | -1.59%39.15M | --56.56M | --32.54M | --44.56M | --39.15M |
| Current changes in cash | -226.75%-15.81M | 162.30%3.07M | -120.10%-4.87M | 64.81%-4.86M | -231.12%-9.14M | 645.41%12.47M | ---4.93M | --24.25M | ---13.82M | --6.97M |
| Effect of exchange rate changes | -116.67%-117K | 6.06%-62K | 20.26%-181K | -111.54%-208K | 121.36%334K | -103.26%-54K | ---66K | ---227K | --1.8M | ---1.56M |
| End cash Position | -30.88%35.64M | -30.88%35.64M | -42.31%32.63M | 15.80%37.69M | -4.04%42.76M | 31.72%51.56M | --51.56M | --56.56M | --32.54M | --44.56M |
| Free cash flow | -6,501.47%-13.47M | 39.41%-2.46M | -182.00%-7.36M | 67.66%-1.87M | -114.51%-1.78M | -101.25%-204K | ---4.06M | ---2.61M | ---5.78M | --12.24M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.